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Mechanisms and function 
Figure  3. Mechanisms  of acƟon and funcƟon  of Foxp3⁺  regulatory T cells  (Campbell and 
Koch 2011)
Function:  establishing chronic infection
Figure 5. Accumulation of Foxp3⁺ regulatory T cells in tumour (Shevach and Davidson,
2010).
Figure 2. Phenotypic markers of Foxp3⁺ regulatory T cells
Figure 4. Function of Foxp3⁺ regulatory T cells in tissues. During infection Treg cells preventing





 Foxp3+ is more frequently expressed in high‐grade gliomas and correlates with the degree of tumour malignancy.
 The Foxp3+ expression is very similar to its human counterpart.
 The canine model could be used for the preclinical evaluation of treatment strategies, such us immunotherapy.
Introduction
Regulatory T cells (Treg), are under investigation for their proposed roles in suppressing
tumour‐specific immune responses and establishing an immunosuppressive tumour
microenvironment, thus enabling to evade immune responses. Understanding Treg
biology and mechanisms in the setting of cancer, and specifically the tumour
microenvironment, is important for designing effective cancer immunotherapies.
 Identification of molecular characteristics, biological rol, mechanisms of action and
prognostic factors of regulatory T cells.
 Immunohistochemical analysis of regulatory T cells using molecular marker Foxp3+.
 Identification of Foxp3+ regulatory T lymphocytes in nervous‐tissue and canine
glioma.
Regulatory T cells 
Figure 1. Development of Foxp3⁺ regulatory T cells (Humphries et al., 2010)
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Figure 6. A: Foxp3 cells in lymph node. B: Foxp3⁺ cells in anaplastic astrocytoma. C: Foxp3⁺ cells in glioblastoma. Tumour cells ( ),
lymphocytes ( )
